These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
337 related items for PubMed ID: 22043776
1. Immunizing children aged 9 to 15 months with live attenuated SA14-14-2 Japanese encephalitis vaccine in Thailand. Chotpitayasunondh T, Sohn YM, Yoksan S, Min J, Ohrr H. J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S195-203. PubMed ID: 22043776 [Abstract] [Full Text] [Related]
2. Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children. Janewongwirot P, Puthanakit T, Anugulruengkitt S, Jantarabenjakul W, Phasomsap C, Chumket S, Yoksan S, Pancharoen C. Vaccine; 2016 Oct 17; 34(44):5279-5283. PubMed ID: 27628323 [Abstract] [Full Text] [Related]
3. A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses. Sohn YM, Tandan JB, Yoksan S, Ji M, Ohrr H. Vaccine; 2008 Mar 20; 26(13):1638-43. PubMed ID: 18294743 [Abstract] [Full Text] [Related]
6. A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea. Kim DS, Houillon G, Jang GC, Cha SH, Choi SH, Lee J, Kim HM, Kim JH, Kang JH, Kim JH, Kim KH, Kim HS, Bang J, Naimi Z, Bosch-Castells V, Boaz M, Bouckenooghe A. Hum Vaccin Immunother; 2014 Mar 20; 10(9):2656-63. PubMed ID: 25483480 [Abstract] [Full Text] [Related]
7. Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12-18 months: randomized, controlled phase 3 immunogenicity and safety trial. Feroldi E, Pancharoen C, Kosalaraksa P, Watanaveeradej V, Phirangkul K, Capeding MR, Boaz M, Gailhardou S, Bouckenooghe A. Hum Vaccin Immunother; 2012 Jul 20; 8(7):929-37. PubMed ID: 22777096 [Abstract] [Full Text] [Related]
9. Long-term follow-up of Japanese encephalitis chimeric virus vaccine: Immune responses in children. Chokephaibulkit K, Sirivichayakul C, Thisyakorn U, Pancharoen C, Boaz M, Bouckenooghe A, Feroldi E. Vaccine; 2016 Nov 04; 34(46):5664-5669. PubMed ID: 27686833 [Abstract] [Full Text] [Related]
10. Is a booster dose necessary in children after immunization with live attenuated Japanese encephalitis vaccine? Choi UY, Lee SY, Kim KH, Kim DS, Choi KM, Cha SH, Kang JH. J Trop Pediatr; 2013 Oct 04; 59(5):423-5. PubMed ID: 23764540 [Abstract] [Full Text] [Related]
11. Long-term immunogenicity of the SA14-14-2 Japanese encephalitis (JE) vaccine (CD.JEVAX®) booster following chimeric JE (IMOJEV®) vaccine priming in Thai children. Chotpitayasunondh T, Suntarattiwong P, Yoksan S. Hum Vaccin Immunother; 2024 Dec 31; 20(1):2407663. PubMed ID: 39353860 [Abstract] [Full Text] [Related]
12. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers. Van Gessel Y, Klade CS, Putnak R, Formica A, Krasaesub S, Spruth M, Cena B, Tungtaeng A, Gettayacamin M, Dewasthaly S. Vaccine; 2011 Aug 11; 29(35):5925-31. PubMed ID: 21723353 [Abstract] [Full Text] [Related]
15. Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine. Woolpert T, Staples JE, Faix DJ, Nett RJ, Kosoy OI, Biggerstaff BJ, Johnson BW, Sracic M, Fischer M. Vaccine; 2012 Apr 26; 30(20):3090-6. PubMed ID: 22406277 [Abstract] [Full Text] [Related]